Structure–Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials
Journal of Medicinal Chemistry · 14.03.2024 · 67 (5) · 3467-3503
DOI: 10.1021/acs.jmedchem.3c01795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.02.2024. Verfasst von John A Gilleran und 19 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Molecular Design and Synthesis Core, Office for Research, Rutgers University, 610 Taylor Road, Piscataway, New Jersey 08854, United States. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Controlling malaria requires new drugs against Plasmodium falciparum. The P. falciparum cGMP-dependent protein kinase (PfPKG) is a validated target whose inhibitors could block multiple steps of the parasite's life cycle. We defined the structure-activity relationship (SAR) of a pyrrole series for PfPKG inhibition. Key pharmacophores were modified to enable full exploration of chemical diversity and to gain knowledge about an ideal core scaffold. In vitro potency against recombinant PfPKG and human PKG were used to determine compound selectivity for the parasite enzyme. P. berghei sporozoites and P. falciparum asexual blood stages were used to assay multistage antiparasitic activity. Cellular specificity of compounds was evaluated using transgenic parasites expressing PfPKG carrying a substituted "gatekeeper" residue. The structure of PfPKG bound to an inhibitor was solved, and modeling using this structure together with computational tools was utilized to understand SAR and establish a rational strategy for subsequent lead optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rutgers Molecular Design and Synthesis Core, Office for Research, Rutgers University, 610 Taylor Road, Piscataway, New Jersey 08854, United States.
- Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, 225 Warren Street, Newark, New Jersey 07103, United States.
- Department of Chemistry and Biochemistry and Sokol Institute of Pharmaceutical Life Sciences, Montclair State University, Montclair, New Jersey 07043, United States.
- Rutgers School of Pharmacy, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, United States.
- Schrödinger, Inc., 1540 Broadway, 24th Floor, New York, New York 10036, United States.
- Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
ORCID-Profile: Levon Halabelian, David P Rotella, Bart L Staker, Purnima Bhanot
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- Congressionally Directed Medical Research Programs
- National Institutes of Health
Zitieren
APA
Gilleran, J. A., Ashraf, K., Delvillar, M., Eck, T., Fondekar, R., Miller, E. B., Hutchinson, A., Dong, A., Seitova, A., De Souza, M. L., Augeri, D., Halabelian, L., Siekierka, J., Rotella, D. P., Gordon, J., Childers, W. E., Grier, M. C., Staker, B. L., Roberge, J. Y., & Bhanot, P. (2024). Structure–Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials. Journal of Medicinal Chemistry, 67(5), 3467-3503. https://doi.org/10.1021/acs.jmedchem.3c01795
Vancouver
Gilleran JA, Ashraf K, Delvillar M, Eck T, Fondekar R, Miller EB, et al. Structure–Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials. Journal of Medicinal Chemistry. 2024;67(5):3467-3503. doi:10.1021/acs.jmedchem.3c01795
BibTeX
@article{Gilleran2024,
author = {Gilleran, John A and Ashraf, Kutub and Delvillar, Melvin and Eck, Tyler and Fondekar, Raheel and Miller, Edward B and Hutchinson, Ashley and Dong, Aiping and Seitova, Alma and De Souza, Mariana Laureano and Augeri, David and Halabelian, Levon and Siekierka, John and Rotella, David P and Gordon, John and Childers, Wayne E and Grier, Mark C and Staker, Bart L and Roberge, Jacques Y and Bhanot, Purnima},
title = {Structure–Activity Relationship of a Pyrrole Based Series of PfPKG Inhibitors as Anti-Malarials},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {5},
pages = {3467--3503},
doi = {10.1021/acs.jmedchem.3c01795}
}
EUVIMED